http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20020080463-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P- |
filingDate | 2001-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2002-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20020080463-A |
titleOfInvention | 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylate and polymorphs |
abstract | The present invention relates to a process for the preparation of 4-amino-6,7-dimethoxy-2- (5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol- -Pyridyl) quinazoline mesylate, a process for their preparation and compositions comprising same:n n n (2)n n n n n n n n The present invention also relates to a substantially pure anhydrous crystalline polymorphic form of the free base. This compound is particularly useful for the treatment of benign prostatic hyperplasia. |
priorityDate | 2000-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.